晚发型颞叶癫痫的认知与生物标志物特征:指向非阿尔茨海默病神经退行性机制
本研究为意大利横断面队列研究,纳入18例脑脊液β-淀粉样蛋白生物标志物正常的晚发型不明原因癫痫(LOUE)患者(表现为颞叶癫痫,LO-TLE)、24例阿尔茨海默病所致轻度认知障碍(MCI-AD)患者和17名健康对照。结果显示LO-TLE皮层厚度和皮层下体积保留,但情景记忆、短时记忆、语言和执行功能较健康对照下降,整体认知优于MCI-AD;其脑脊液神经丝轻链(NfL)水平低,磷酸化/总tau比值(p/t-tau)低于0.17,提示其病理机制独立于阿尔茨海默病。
要点
- LO-TLE患者影像学结构保留,但记忆、语言和执行功能受损而注意力保留。
- LO-TLE的脑脊液NfL水平低,p/t-tau比值低于0.17,不支持阿尔茨海默病病理。
- LO-TLE中较高的p/t-tau比值与更好的整体认知和短时记忆相关。
核心结论
- 脑脊液阿尔茨海默病生物标志物正常的LO-TLE具有独特的认知和生物学特征,提示其疾病过程独立于阿尔茨海默病。
研究设计与样本
- 意大利横断面队列研究,纳入18例LO-TLE、24例MCI-AD和17名年龄性别匹配的健康对照,进行结构MRI、神经心理评估和脑脊液生物标志物检测。
主要发现
- LO-TLE皮层厚度和皮层下体积与健康对照相当,而MCI-AD呈现广泛皮层变薄和海马萎缩。
- LO-TLE在情景记忆(t(53)=-7.79,pFDR<0.001)、短时记忆(t(53)=-2.94,pFDR=0.007)、语言(t(53)=4.12,pFDR<0.001)和执行功能(t(53)=-3.76,pFDR<0.001)上较健康对照差,注意力保留。
- LO-TLE整体认知表现优于MCI-AD(t(53)=4.21,pFDR<0.001)。
- LO-TLE脑脊液NfL水平低,p/t-tau比值低于0.17;MCI-AD则显示病理性Aβ和tau改变、NfL升高及p/t-tau比值高于0.17。
- LO-TLE中较高的p/t-tau比值与更好的整体认知(rs=0.585,pFDR=0.032)和短时记忆(rs=0.588,pFDR=0.032)相关,MCI-AD中无此关联。
关键数值与推荐
- LO-TLE的p/t-tau比值低于提出的cutoff值0.17,MCI-AD高于0.17。
临床怎么用
- 对于晚发型颞叶癫痫患者,即使脑脊液AD生物标志物正常,也应关注其记忆、语言和执行功能损害。
- 脑脊液NfL和p/t-tau比值有助于区分LO-TLE与MCI-AD,前者NfL低且p/t-tau比值低于0.17。
局限性
- 样本量较小(LO-TLE 18例,MCI-AD 24例,健康对照17名),需更大规模纵向研究验证。
- p/t-tau比值低的病理生理机制尚不明确,需进一步探究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Late-onset unexplained epilepsy (LOUE) represents a substantial proportion of epilepsies with onset after 50 years and often manifests as temporal lobe epilepsy (LO-TLE). Although a link with Alzheimer disease (AD) has been suggested, only a subset of LO-TLE shows AD-related biomarkers, indicating biological heterogeneity. This study aims to characterize the cognitive and CSF phenotype of LO-TLE and compare it with healthy controls (HCs) and patients with mild cognitive impairment due to AD (MCI-AD). METHODS: This Italian cross-sectional cohort study included LO-TLE patients with normal CSF β-amyloid (Aβ) biomarkers, MCI-AD, and age-matched and sex-matched HC. Participants underwent structural MRI, neuropsychological assessment, and CSF biomarkers assay, including neurofilament light chain (NfL) and the phosphorylated-to-total tau ratio (p/t-tau). Cortical thickness and subcortical volumes were quantified from structural MRI. Cognitive performance was summarized using principal component analyses. Group differences in imaging, cognition, and CSF biomarkers were assessed, and associations between CSF markers and cognition were examined within groups. RESULTS: The study included 18 LO-TLE, 24 MCI-AD, and 17 HC. LO-TLE showed preserved cortical thickness and subcortical volumes comparable with HC, whereas MCI-AD exhibited widespread cortical thinning and medial temporal atrophy. Despite normal imaging, LO-TLE showed lower performance compared with HC in episodic memory (t(53) = -7.79, pFDR < 0.001), short-term memory (t(53) = -2.94, pFDR = 0.007), language (t(53) = 4.12, pFDR < 0.001), and executive functions (t(53) = -3.76, pFDR < 0.001), while attention was preserved. Global cognitive performance further distinguished LO-TLE from MCI-AD, with the former group performing better (t(53) = 4.21, pFDR < 0.001). LO-TLE CSF profiles were characterized by low NfL levels and a p/t-tau ratio below the proposed cutoff of 0.17, whereas MCI-AD showed pathologic Aβ and tau alterations, elevated NfL, and p/t-tau ratio above 0.17. In LO-TLE, a higher p/t-tau ratio was associated with better performance on global cognition (rs = 0.585, pFDR = 0.032) and short-term memory (rs = 0.588, pFDR = 0.032), whereas no associations emerged in MCI-AD. DISCUSSION: LO-TLE with normal CSF AD biomarkers is characterized by distinct cognitive and biological features compared with MCI-AD, suggesting a disease process independent of AD. The low p/t-tau ratio may reflect alternative pathophysiologic mechanisms and warrants further investigation in larger longitudinal studies to clarify the underlying pathology and clinical trajectories.
引用
- Casarini A, Ballerini A, Maramotti R, et al. Cognitive and Biomarker Signatures of Late-Onset Temporal Lobe Epilepsy: Toward Non-Alzheimer Neurodegenerative Mechanisms. Neurology. 2026. PMID: 42550989. doi:10.1212/WNL.0000000000218356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。